Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Bioject (US) makes appointment:

This article was originally published in Clinica

Executive Summary

Developer of needle-free drug delivery systems Bioject (Bedminster, New Jersey) has appointed Eric Mishkin as senior vice-president and chief scientific officer. Dr Mishkin, who has over 25 years of experience in immunology research and microbiology, most recenly served as director of immunology research at Wyeth-Ayerst. It has also announced the appointment of Chris Pugh, who has over 10 years of product and business development experience, as director of business development.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066518

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel